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R E S E A R C H
Impact of Massage Therapy on Fatigue, 
Pain, and Spasticity in People with 
Multiple Sclerosis: a Pilot Study
Background: Multiple sclerosis (MS) is a chron-
ic, immune-mediated, inflammatory disease that 
leads to fatigue, pain, and spasticity, as well as 
other sensorimotor and cognitive changes. Often 
traditional medical approaches are ineffective in 
alleviating these disruptive symptoms. Although 
about one-third of surveyed individuals report 
they use massage therapy (MT) as an adjunct to 
medical treatment, there is little empirical evi-
dence that MT is effective for symptom manage-
ment in people with MS.
Purpose: To measure the effects of MT on fa-
tigue, pain, spasticity, perception of health, and 
quality of life in people with MS.
Setting: Not-for-profit long-term care facility. 
Participants: Twenty-four of 28 enrolled in-
dividuals with MS (average age = 47.38, SD = 
13.05; 22 female) completed all MT sessions and 
outcome assessments. 
Research Design: Nonrandomized, pre–post 
pilot study.
Intervention: Standardized MT routine one time 
a week for six weeks. 
Main Outcome Measure(s): Modified Fatigue 
Index Scale (MFIS), MOS Pain Effects Scale 
(MOS Pain), and Modified Ashworth Scale 
(MAS). Secondary outcome measures: Mental 
Health Inventory (MHI) and Health Status Ques-
tionnaire (HSQ).
Results: There was a significant improvement 
in MFIS (p < .01), MOS Pain (p < .01), MHI (p < 
.01), and HSQ (p < .01), all with a large effect size 
(ES) (Cohen’s d = -0.76, 1.25, 0.93, -1.01, respec-
tively). There was a significant correlation between 
change scores on the MFIS and the MOS Pain (r 
= 0.532, p < .01), MHI (r = -0.647, p < .01), and 
subscales of the HSQ (ranging from r = -0.519, to 
-0.619, p < .01).
Conclusions: MT as delivered in this study is a 
safe and beneficial intervention for management 
of fatigue and pain in people with MS. Decreasing 
fatigue and pain appears to correlate with im-
provement in quality of life, which is meaningful 
for people with MS who have a chronic disease 
resulting in long-term health care needs.
KEY WORDS: multiple sclerosis; therapeutic mas-
sage; fatigue; pain; spasticity; symptom management
iNtRoduCtioN
Multiple sclerosis (MS) is a chronic, immune-
mediated, inflammatory disease of the central nervous 
system affecting over two million people world-wide.
(1) The different patterns of inflammation, scarring, de-
myelination, and axonal damage that occur throughout 
the brain and spinal cord lead to varying symptoms 
that ultimately limit function and lead to disability. 
The resulting loss of independence and restrictions 
on recreational, vocational, and social activities, 
leads to a progressive decline in quality of life. While 
disease-modifying therapies may prevent or slow the 
progression of the disease, many symptoms remain, 
even with the use of these medications.(2)
Fatigue, pain, and spasticity are three disruptive 
symptoms in people with MS. Fatigue is the most 
commonly reported and affects daily activities and 
employment in over half of people with MS, rang-
ing from 53%–87%.(3-9) Pain, too, affects a large 
number of people with MS, anywhere from 30% 
to 90%, depending on the study and the participant 
characteristics.(10-13) About 80% of people with MS 
report they have spasticity, or an increase in response 
to stretch and movement that is disruptive to everyday 
function, personal care, and mobility.(14-16) As fatigue, 
pain, and spasticity increase in people with MS, mo-
bility and everyday tasks become more difficult and 
quality of life (QOL) decreases.(17-19) Interventions 
are needed to address these symptoms without side 
effects, in order to improve QOL in people with MS, 
especially given that they are expected to live a nearly 
full lifespan with this chronic condition.(16)
Approximately a third of surveyed individuals 
with MS report they use massage therapy (MT) as 
an adjunct to their medical treatment, often because 
conventional treatments are not effective in managing 
their symptoms.(20,21) While various lines of research 
demonstrate that MT can improve QOL in people with 
MS,(21-25) and decrease fatigue, pain, and spasticity in 
other patient populations,(26-33) there is little empirical 
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Participants were recruited by word of mouth, 
RRC–approved fliers, and through the patient data-
base at the Shepherd Center in Atlanta, Georgia. We 
aimed to enroll 25 participants; thus, if a participant 
dropped out of the study, we recruited another in order 
to complete data collection on 25 people with MS. 
All participants received the intervention. 
outcome Measures
The following outcome measures were collected 
before and after completion of the six-week inter-
vention phase, but not immediately after a massage 
session. All were collected by the study coordinator, 
except for the Modified Ashworth Scale (MAS),(34) 
which was performed by a trained physical therapist.
The primary outcome measures were the Modified 
Fatigue Index Scale (MFIS),(35-38) the Modified Ash-
worth Scale (MAS; spasticity),(34) and the MOS Pain 
Effects Scale  Secondary outcome measures included 
assessment of perception of health and quality of life 
using subscales of the MS QLI.(38) Outcome measures 
are described in Table 1.
Massage therapy intervention
A specific routine of MT(39) was designed by two 
study investigators who are licensed physical thera-
pists and licensed massage therapists. Tables 2 and 
3 provide details regarding the specific routine. In 
general, the MT routine consisted of a combination 
of effleurage, petrissage, friction, and static compres-
sion strokes.(40) Effleurage (E) was defined as using a 
evidence supporting MT for symptom management. 
The purpose of this study was to measure the effects 
of six weeks of a standardized massage routine on fa-
tigue, pain, spasticity, perception of health, and QOL 
in people with MS. Our main hypothesis was that MT 
would decrease participant complaints of fatigue, 
pain, and spasticity. Secondarily, we hypothesized 
that reduction in these impairments would lead to 
improved perception of health and QOL.
MEthodS
This is a nonrandomized, pre–post design pilot 
study. This study was approved by the Research Re-
view Committee (RRC) of the Shepherd Center prior 
to initiation of any study procedures. 
participants
We recruited any individual with medically con-
firmed MS who did not have medical complications 
that would affect their safety with receiving MT. 
Individuals were excluded if they had any of the 
following: unmanaged DVT; uncontrolled hyperten-
sion; unstable fractures; other neurological injury or 
disease; pregnant or trying to get pregnant; received 
MT in the past six months; weight exceeds 350 lbs. 
(due to capacity of equipment); unable to get out of 
wheelchair to safely transfer to massage table; un-
able to be safely and comfortably positioned on a 
massage table in order to receive the standardized 
massage routine.
BACKUS: IMPACT OF MT ON MS PATIENTS
Table 1. Outcome Measures
Outcome Measure Description Interpretation
Modified Fatigue Impact Scale (MFIS) 5-item tool included in the MS Quality of 
Life Index (MS QLI) that assesses physical, 
cognitive and psychosocial fatigue.(35-38) 
Scores range from 0–20, with a lower 
score indicating less fatigue
Modified Ashworth Scale (MAS) Clinician reported outcome measure to score 
spasticity in all 4 extremities. 
Scores range from 0 (no spasticity) to 4 
(severe spasticity)
A total score was calculated for each leg
A lower score indicates less spasticity
MOS Pain Effects Scale 6-item participant reported questionnaire 
included in the MS QLI to assess the degree to 
which pain interferes with mood, and ability to 
move, sleep, work, participate in recreation and 
enjoy life.
Scores range from 6–30
A lower score indicates less pain
Mental Health Inventory (MHI) 18-item participant reported questionnaire to 
assess emotional and mental health 
Scores range from 0 to 100 
A higher score indicates the perception of 
better mental health
Health Status Questionnaire 
(HSQ or SF-36)
36-item participant reported questionnaire to 
measure QOL included in the MS QLI.
Scores range from 0 to100
A higher score indicates better QOL
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was defined as deep pressure using pad of thumbs or 
fingers bidirectionally across the grain of musculature, 
superficial layers of tissue moving over deeper mus-
cles. Static Compression (SC) was applied using deep 
pressure with the pad of thumbs statically, intended to 
pin a trigger point nodule, adhered tissue, or otherwise 
identified area of tissue dysfunction against deeper 
tissue or bone. SC was generally held for 8–12 s, but 
longer and shorter duration holds were performed at 
therapist discretion. Participants received this specific 
routine of MT for approximately 1 hr each week, for 
six weeks, in a quiet room, on a massage table, by a 
licensed massage therapist (LMT). 
Two primary LMTs and one investigator were 
trained in the MT routine. Two of the study 
investigators, also LMTs, filmed a video of delivery 
gliding stroke of superficial pressure performed with 
palmar surface of hands at a consistent rhythm with 
a smooth, continuous motion that did not lose contact 
with the skin until completion of a described stroke. 
Hand-over-hand effleurage (E, hand-over-hand) was 
applied according to this same description, but further 
defined as rhythmic alternation of hands at more rapid 
rate of speed (approximately one second each hand). 
Petrissage (P) was defined as a lifting/kneading motion 
using a lumbrical grip of moderate pressure, resulting 
in the shifting of different muscular structures against 
one another, and/or of muscle tissue being lifted from 
underlying structures. Friction was applied using ei-
ther linear friction (LF) or cross-fiber friction (XFF). 
LF was defined as deep pressure using pad of thumbs 
with compressive force along length of muscle; XFF 
Table 2. Massage Routine in Prone (Participant positioned in prone, or in as close approximation to prone as possible within given comfort 
and ROM restrictions, bolster support as appropriate (4” foam wedge under ankles))
Body Part (Time in min) Stroke/Location Details
Back (15) E, caudally beginning on superior aspect of shoulders, descending to iliac crest 5 strokes
E, hand-over-hand caudally on R side of back from superior aspect of shoulders to iliac crest, 
followed by cephalically on R side of back from iliac crest to superior aspect of shoulders
5 passes
P, R side of back from iliac crest to superior scapula 5 passes 
P, R upper trapezius from acromioclavicular joint to base of cervical spine 5 passes 
P, perispinal musculature from base of cervical spine (C7) to occiput 5 passes 
LF, caudally along lamina groove on R side from C7 to iliac crest 5 strokes 
LF, from junction of lumbar spine (L5) and iliac crest to lat edge of quadratus lumborum,  
R side
5 strokes 
E, hand-over-hand caudally on L side of back from superior aspect of shoulders to iliac crest, 
followed by cephalically on L side of back from iliac crest to superior aspect of shoulders
5 passes 
P, L side of back from iliac crest to superior scapula 5 passes 
P, L upper trapezius from acromioclavicular joint to base of cervical spine 5 passes 
P, perispinal musculature from base of cervical spine (C7) to occiput 5 passes 
LF, caudally along lamina groove on L side from C7 to iliac crest 5 strokes 
LF, from junction of L5 and iliac crest to lat edge of quadratus lumborum, L side 5 strokes 
Post RLE (7) E, from Achilles tendon to hamstring attachment.  5 strokes 
P, on gastroc/soleus from Achilles tendon to 1” inferior to popliteal fossa 5 passes 
E, hand-over-hand along med post thigh from med femoral condyle to 2” inferior to pubic 
symphysis (adductors/hamstrings)
5 passes 
P, med post thigh from med femoral condyle to 2” inferior to pubic symphysis (adductors/
hamstrings) 
5 passes 
E, hand-over-hand along lat post thigh from lat femoral condyle to greater trochanter 
(hamstrings/IT band)
5 passes 
P, lat post thigh from lat femoral condyle to greater trochanter (hamstrings/IT band) 5 passes 
Post LLE (7) E, from Achilles tendon to hamstring attachment 5 strokes
P, gastroc/soleus from Achilles tendon to 1” inferior to popliteal fossa 5 passes 
E, hand-over-hand med post thigh from med femoral condyle to 2” inferior to pubic symphysis 
(adductors/hamstrings)
5 passes 
P, med post thigh from med femoral condyle to 2” inferior to pubic symphysis  
(adductors/hamstrings) 
5 passes 
E, hand-over-hand lat post thigh from lat femoral condyle to greater trochanter  
(hamstrings/IT band)
5 passes 
P, lat post thigh from lat femoral condyle to greater trochanter (hamstrings/IT band) 5 passes 
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Table 3. Massage Routine in Supine (Participant positioned in supine, or in as close approximation to supine as possible within given comfort 
and ROM restrictions, bolster support as appropriate (4” foam wedge under knees). Five minutes allowed for transition from prone to supine.)
Body Part (Time in min) Stroke/Location Details
Ant RLE (7) E, 1” superior to med/lat malleoli to ASIS  5 strokes 
LF, along tibialis ant 5 strokes
E, hand-over-hand, med thigh from 1” superior to med femoral condyle to 2” 
inferior to pubic symphysis 
5 passes 
P, med ant thigh from med femoral condyle to 2” below pubic symphysis 
(adductors/quadriceps)
5 passes 
E hand-over-hand, lat thigh from 1” superior to lat femoral condyle to ASIS 5 passes 
P, lat ant thigh from lat femoral condyle to greater trochanter (quadriceps/IT band) 5 passes 
Ant LLE (7) E from 1” superior to med/lat malleoli to ASIS 5 strokes 
LF, along tibialis ant 5 strokes
E, hand-over-hand, med thigh from 1” superior to med femoral condyle to 2” inferior 
to pubic symphysis 
5 passes 
P, med ant thigh from med femoral condyle to 2” below pubic symphysis 
(adductors/quadriceps) 
5 passes 
E, hand-over-hand, lat thigh from 1” superior to lat femoral condyle to ASIS 5 passes 
P, lat ant thigh from lat femoral condyle to greater trochanter (quadriceps/IT band) 5 passes 
RUE (7) E, forearm from wrist crease to 1” inferior to cubital fossa, alternating hands to cover 
full ant/post surfaces of forearm
5 strokes each side
P, using single hand on forearm from wrist crease to 1” inferior to cubital fossa 
(opposing hand stabilizes arm)
5 passes 
E, prox arm from 1” superior to cubital fossa to humeral head, alternating hands to 
cover full ant/post surfaces of prox arma
5 stokes each side
P, using single hand on prox arm from 1” superior to cubital fossa to humeral heada 5 passes 
E along pectoralis major/ant surface of arm from inferior to clavicle to hand 5 strokes
Light kneading pressure using pad of thumbs on palmar surface of hand (hand 
supported on therapist’s hands)
30 s
LUE (7) E, forearm from wrist crease to 1” inferior to cubital fossa, alternating hands to cover 
full ant/post surfaces of forearm
5 strokes each side
P using single hand on forearm from wrist crease to 1” inferior to cubital fossa 
(opposing hand stabilizes arm)
5 passes 
E, prox arm from 1” superior to cubital fossa to humeral head, alternating hands to 
cover full ant/post surfaces of prox arma
5 passes 
P, using single hand on prox arm from 1” superior to cubital fossa to humeral heada 5 passes 
E, along pectoralis major/ant surface of arm from inferior to clavicle to hand 5 strokes
Light kneading pressure using pad of thumbs on palmar surface of hand (hand 
supported on therapist’s hands)
30 s
Neck/Head and Shoulders (8) E, occiput to acromioclavicular joint on the R 5 strokes
LF, occiput to C7 5 strokes
LF, C7 to acromioclavicular joint 5 strokes
XFF to sub-occipitals on the R  15 s
SC to sub-occipitals on R  15 s
E, occiput to acromioclavicular joint on the L 5 strokes
LF, occiput to C7 5 strokes
LF, C7 to acromioclavicular joint 5 strokes
XFF to suboccipitals on the R  15 s
SCto suboccipitals on L  15 s
30 s
Positional Elongation/Passive stretching into cervical side-bending to L (stretching to upper trapezius and middle scalene)
Positional Elongation/Passive stretching into cervical side-bending to R (stretching to upper trapezius and middle scalene)
a If subject is able, arm positioned behind head with shoulder flexion and elbow flexion; if unable, arm remains by side.
Ant = anterior; LF = linear friction; E = effleurage; E, hand-over-hand = effleurage, hand-over-hand; L = left; Lat = lateral; LE = lower 
extremity; Med = medial; Min = minutes; P = Petrissage; XFF = Cross-fiber friction; SC = static compression; Post = posterior; Prox = 
proximal; R = right; s = seconds.
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massage, they were rescheduled for another session. 
If the massage lasted for at least 30 consecutive min-
utes, the massage was deemed complete and another 
session was not scheduled. If a participant missed a 
session, every attempt was made to reschedule this 
session during the same week of the missed ses-
sion. If that was not possible, then the massage was 
rescheduled at the end of all of the sessions. All six 
sessions for massage were completed within an eight-
week period. If a participant withdrew or dropped 
out of the study, another participant was recruited to 
replace them. The only exception was that one of the 
last participants dropped out of the study at the time 
of her final massage and would not return for testing. 
Another participant was not recruited given that the 
study time period (one year) had ended. 
Analysis 
All data were collected on paper forms and kept 
in a locked cabinet. Data were entered into an Excel 
spreadsheet and a statistical software program (SPSS 
version 15.0 for Windows) by a study co-investigator 
and checked for quality and completeness by the 
principal investigator. 
We employed descriptive statistics to evaluate 
means and standard deviations. Paired t tests were 
used to determine statistically significant differ-
ences pre- and postintervention in fatigue (MFIS), 
pain (MOS Pain) and spasticity (MAS), perception 
of health (MHI), and QOL (HSQ). Correlational 
analyses were conducted to examine the relation-
ship between fatigue, pain, and spasticity, percep-
tion of health (MHI) and QOL (HSQ). We employed 
Spearman’s rho correlation coefficients to estimate 
correlation coefficients to determine if there was 
of the specified routine for training. The LMTs first 
viewed this video and, once familiar with the routine, 
they performed it on two volunteers. One investiga-
tor observed the session to assess adherence to the 
routine and to provide feedback related to timing and 
sequencing. Once the LMTs demonstrated compe-
tency with the routine, the LMTs began providing this 
routine to participants for the study. Specific instruc-
tions were not given regarding speed of strokes; the 
speed of each stroke was implied in the overall time 
period associated with the body area addressed. Level 
of pressure was determined relative to participant tol-
erance, particularly with the techniques of petrissage, 
linear friction, and static compression. All attempts 
were made to assure that the same primary LMT 
administered all six massages on a given participant. 
However, if a primary LMT was not available for 
some reason, the other primary LMT or the trained 
investigator administered the MT for that session. 
At the completion of each session, the LMT com-
pleted the Process Evaluation Form (Table 4), to 
indicate any deviation from the routine during that 
session. The Process Evaluation Forms were reviewed 
by a coinvestigator weekly to ascertain the routine 
was followed by the LMT. If there were any devia-
tions to the protocol, the coinvestigator followed up 
with the LMT to discuss and resolve any issues. In 
addition, the study coordinator and a coinvestigator 
reviewed these data sheets regularly to make sure 
that all data points were complete. If a data point was 
missing, the study coordinator contacted the LMT to 
determine if the data point could be captured, and the 
principal investigator was notified. In all cases, the 
data were retrieved from the LMT and documented. 
If a massage was stopped for any reason and the 
participant had received less than 30 min of the 1-hour 
Table 4. Process Evaluation Form
Massage Weekly Process Evaluation Form
Therapist _________ Session Number ________ Date ________
1) Effects of last massage / “subjective”
2) Current Pain level: VAS and location prior to massage
3) Was patient position altered from standard prone and supine ? No Yes (if yes how)
4) Massage routine: sequence change? No Yes (if yes, please note how and why)
5) Massage routine: pacing change? No Yes (if yes, please note how and why)
6) Massage routine: skip items? No Yes (if yes, please note how and why)
7) Did you complete the massage routine? No Yes (if no, please describe why)
8) Deviation from protocol (something added?) No Yes (if yes, please note below)
9) Session ends on time No Yes
10) Please note anything else pertinent to the session evaluation that may not have been covered in the previous questions.
11) Current Pain level: VAS and location post to massage
Before say goodbye
Next appointment date confirmed No Yes
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Fatigue, pain, and Spasticity
Table 4 presents the findings from the paired t tests. 
Twenty-two of the 24 participants reported a decrease 
in fatigue. There was a significant decrease in MFIS 
scores from pre- to post-testing (p < .01), indicating a 
decrease in self-reported fatigue after the intervention. 
One participant reported no change after the interven-
tion, and one reported a slight increase (total score 13 
pre and 15 post). There also was a significant 18% 
decrease in pain (p < .01) as indicated by the MOS 
Pain scores after the intervention. 
A complete MAS was collected on 19 of the 24 
participants. Five participants were not assessed 
due to timing of the assessment, transportation is-
sues, and evaluator unavailability. Only 16 of those 
19 reported any spasticity at the onset of the study, 
with scores ranging from 1 (slight increase in muscle 
tone, manifested by a catch and release or by minimal 
resistance at the end of the range of motion when the 
affected part(s) is moved in flexion or extension) to 3 
(considerable increase in muscle tone, passive move-
ment difficult) for these participants. There was no 
significant increase or decrease in the MAS in this 
group after the intervention in either the left or right 
leg (p = .17 and .23, respectively). 
Effect sizes (ES) for measures of fatigue, pain, 
and spasticity are found in Table 5. There was a large 
negative ES for MFIS and MOS Pain, and a small 
negative ES for MAS, both right and left leg. 
a relationship between changes in symptoms and 
participant reports of health and QOL. Statistical 
significance was determined with a value equal to or 
less than alpha level of 0.05. 
In addition, we analyzed the data to assess 
clinically meaningful change, using the definition: 
“Clinically meaningful change can be defined as a 
noticeable, appreciable difference that is of value to 
the patient or the health professional, and that exceeds 
variation attributable to chance.”(41) Based on Cohen, 
effect sizes of 0.2 are considered small, 0.5–0.6 are 
considered medium, and 0.8 are considered large.(42)
RESultS
participants
Twenty-eight individuals with MS were enrolled 
in this study, and 24 completed all MT sessions and 
outcome measures. The majority (n = 22) were fe-
male, the mean age was 47.38 years (range = 24–71, 
standard deviation (SD) = 13.05), and the mean time 
since diagnosis was 12.68 years (range = 2–25 years, 
SD = 6.13). Two participants did not know the time 
since diagnosis. Two participants dropped from the 
study due to transportation or family issues, one due 
to medical reasons, and a fourth was dropped due to 
no longer meeting the enrollment criteria after being 
enrolled. There were no adverse events in this study. 
Table 5. Descriptive Statistics, Comparison of Means Using Paired t Tests, and Effect Sizes Using Cohen’s d (n = 24)
Pre Post Paired Differences
Measure
(Range of Scores)
Mean
(SD, SE Mean)
Mean
(SD, SE Mean)
Mean SD SE Mean p Cohen’s da
Modified Fatigue Impact Scale
(0–20)
12.00 (3.67, 0.75) 7.92 (3.65, 0.74) 4.08 4.03 .823 < .01 -1.01
MOS Pain Effects Scale 
(6–30)
18.46 (5.79, 1.18) 13.92 (4.74, 0.98) 4.54 5.96 1.22 < .01 -0.76
Mental Health Inventory
(0–100)
64.95 (13.34, 2.72) 78.24 (11.96, 2.44) -13.29 10.62 2.17 < .01 1.25
Health Status Questionnaire 
(0–100)
Total Score 91.58 (12.27, 2.51) 103.00 (14.55, 2.97) -11.13 13.64 2.79 < .01 0.93
General Health 55.08 (10.84,2.21) 55.71 (13.73, 2.80) -3.63 12.04 2.46 .15 0.30
Physical Functioning 37.50 (21.87,4.46) 42.71 (25.02, 5.11) -5.21 25.39 5.18 .33 0.21
Role-Physical 20.83 (24.08,4.92) 51.04 (37.94, 7.74) -30.21 42.97 8.77 < .01 0.70
Bodily Pain 39.04 (20.76, 4.24) 56.38 (19.45, 3.97) -17.33 16.66 3.40 < .01 1.04
Role-Emotional 45.75 (35.27, 7.20) 70.83 (35.86, 7.31) -25.08 40.83 8.34 .01 0.61
Vitality 35.21 (18.68, 3.81) 51.04 (17.57, 3.59) -15.83 19.37 3.96 < .01 0.82
Mental Health 68.67 (15.50, 3.16) 80.00 (12.32, 2.51) -11.33 11.42 2.33 < .01 0.99
Social Functioning 60.42 (26.50, 5.41) 75.00 (23.02, 4.70) -14.83 27.75 5.66 .02 0.53
aEffect sizes (Cohen’s d) of 0.2 are considered small, 0.5–0.6 are considered medium, and 0.8 are considered large.
SD = standard deviation; SE Mean = standard error of the mean.
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negatively correlated with total MHI score (r = -0.584, 
p < .01) and Role-Physical subscale of the HSQ (r = 
-599, p < .01), also indicating that as pain decreased, 
these measures of QOL increased. There were no 
other statistically significant relationships between 
fatigue (MFIS), pain (MOS Pain), and health (MHI) 
or QOL (HSQ) measures. 
diSCuSSioN
This pilot study is the first to demonstrate the posi-
tive impact of a standardized massage therapy (MT) 
routine on fatigue and pain, as well as perception 
of health and quality of life (QOL) in individuals 
with MS. These findings are meaningful given the 
prevalence of fatigue and pain in people with MS, 
and the extent to which these symptoms impact an 
individual’s perception of health and QOL.(8,10,17) We 
failed to find a similar reduction of spasticity after 
MT in our participants with MS. 
Our finding that fatigue and pain were both sig-
nificantly decreased in our participants with MS after 
MT is not surprising given that MT has been shown 
to decrease fatigue and pain in people with chronic 
fatigue syndrome(32) and fibromyalgia syndrome,(31) 
both chronic diseases significantly impacting the 
health and well-being of individuals in a fashion 
similar to MS. 
The pathophysiology underlying fatigue in MS is 
unclear and each individual’s experience of fatigue is 
different and variable over the course of the disease. 
Putative mechanisms being explored in an effort to 
better understand the pathophysiology of MS fatigue 
include the influence of proinflammatory cytokines, 
central nervous system lesion load, cortical atrophy 
and abnormal patterns of cerebral activation, poor 
perception of health and Quality of life
All participants (n = 24) completed the MHI and 
HSQ. There was a significant increase in the total 
MHI (p < .01) and in all subscales of the MHI as well, 
indicating an overall improvement in mental health. 
However, there were some participants who did not 
improve on the anxiety subscale (n = 3), depression 
subscale (n = 1), and the positive affect subscale (n = 
3). Two experienced a decrease in both the Behavior 
Control and Positive Affect subscale. 
There was a significant increase in the Role-Physical 
(p < .01), Bodily Pain (p < .01), Role-Emotional (p = 
.01), Vitality (p < .01), Mental Health (p < .01), and 
Social Functioning (p = .02) subscales of the HSQ, 
indicating an improvement in these aspects of QOL. 
There was a large ES for the MHI and all sub-
scales of the HSQ, except for the HSQ General 
Health and Physical subscales, which were small, 
and the Emotional and Social subscales, which 
were medium. 
Relationships Between Measures
Table 6 provides details regarding the correlations 
between measures. Significant correlations include 
change in total MFIS score being positively correlated 
with total MOS Pain change score (r = 0.532, p = .01). 
Furthermore, change in MFIS score was negatively 
correlated with total MHI change (r = -0.647, p < .01) 
and the change scores for the Physical Functioning 
(r = -0.544, p = .01), Role-Physical (r = -0.576, p < 
.01), Bodily Pain (r = -0.57, p < .01), Role-Emotional 
(r = -0.543, p = .01) and Social (r = -0.519, p = .01) 
subscales of the HSQ. This indicates that as fatigue 
decreased, these measures of QOL increased (i.e., 
improved). Change in total MOS Pain score was 
Table 6. Correlations Between Measures
MOS
Pain
MHI
Physical 
Function
Role -
Physical
Bodily  
Pain
Role 
-Emotional
Vitality
Mental 
Health
Social 
Function
MFIS .532a -.647a -.544a -.576a -.572a -.543a -.619a -.245 -.519a
MOS Pain -.584a -.197 -.599a -.361 -.363 -.158 -.208 -.385
MHI .375 .561a .308 .576a .487b .686a .670a
Health Status Questionnaire
Physical Function .431b .463b .283 .583a .136 .331
Role -Physical .270 .497b .209 .217 .512b
Bodily Pain .130 .483b .052 .340
Role -Emotional .574a .233 .484b
Vitality .382 .475b
Mental Health .595a
a p < .01
b p < .05
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endocrine influences and axonal injury.(43) In addition, 
muscle fatigue has also been demonstrated in people 
with MS(44) and may contribute to the overall fatigue 
reported by individuals with MS. Thus, this lack of 
clarity related to fatigue in MS makes it difficult to 
understand the potential mechanisms by which MT 
may have a positive impact on fatigue.(45-48) 
MT has also been shown to be effective for decreas-
ing neuropathic pain in some people with spinal cord 
injury.(27) Roberts(28) reported that light to moderate 
massage led to a decrease in the gain of the spinal 
nociceptive reflexes, which are often elevated in 
chronic pain syndromes. Although we did not explore 
potential mechanisms for the changes seen in our 
participants with MS, MT may also be effective in 
decreasing pain in people with MS through mecha-
nisms similar to those described by Roberts.(28) 
As fatigue and pain increase in people with MS, 
QOL decreases.(14,17-19) The fact that we found that 
decreases in fatigue and pain are related to improve-
ments in perception of health and QOL is meaningful, 
considering that at this time there is neither a cure for 
MS, nor an adequate treatment for fatigue or pain for 
people with MS. Furthermore, medications for man-
agement of fatigue and pain are costly, and MT may 
provide a relatively inexpensive and accessible option 
for decreasing these symptoms and, thereby, improve 
perception of health and QOL in people with MS. 
Although others have demonstrated a decrease in 
spasticity after a massage intervention in individu-
als with neurological disorders,(21) we did not find a 
significant decrease in spasticity in our participants 
with MS. One explanation is that earlier studies 
evaluated spasticity immediately or within 30 min 
following an MT session,(21) and we only assessed 
spasticity at the end of the six-week intervention 
period and not immediately following a single MT 
session. Furthermore, the MT routine appeared to be 
different than the one utilized for our study. For in-
stance, although Malila et al.(29) reported a decrease in 
spasticity, they utilized a Thai massage; Goldberg et 
al.(30) found benefits only with a deep tissue massage 
using a one-handed petrissage technique; Brouwer 
and de Andrade(21) utilized slow stroking. The MT 
routine in our study employed both petrissage and 
effleurage techniques. Perhaps, had we used the same 
type of massage as employed in these earlier stud-
ies, we might have seen a different response in their 
spasticity. However, it is important to note that the 
literature related to massage and spasticity is small 
and the reports variable. 
A significant finding from this study is that the MT 
routine provided did not increase spasticity in our 
participants. Only three of our participants actually 
reported spasticity at the onset of the study, and hence 
this may explain the lack of improvement. Another 
potential explanation for not finding a reduction in 
spasticity in our study participants is that the outcome 
measure we used to assess spasticity, the Modified 
BACKUS: IMPACT OF MT ON MS PATIENTS
Ashworth Scale, only assesses whether there is hyper-
tonia or a velocity dependent resistance to stretch,(34) 
whereas other studies utilized tests of H-reflex excit-
ability(21,30) or joint range of motion.(21,49) The fact 
that our participants did not experience a significant 
decrease in spasticity may be because we did not use 
a targeted intervention to directly address the muscles 
having spasticity, which we have previously shown 
decreased spasticity in one person with spinal cord 
injury.(33) Further research is warranted to assess the 
long-term effects on spasticity utilizing other MT 
approaches in people with MS. 
Limitations of this study include the small size 
and the lack of a control group. In addition, while 
all attempts were made to standardize the delivery 
of the massage routine provided in this study, we did 
not control for the amount of pressure provided. This 
would be an important consideration for future stud-
ies, given that there is evidence that different amounts 
of pressure can elicit unique responses.(49-51)
Other variables not studied in this study include 
depression(52) and sleep disorders, both common 
symptoms reported by people with MS. Both have 
been shown to influence fatigue in people with MS, 
and both have been reported to decrease after MT in 
other patient populations. A careful consideration of 
depression and sleep disorders would be warranted 
in future studies. 
CoNCluSioN
These findings suggest that massage therapy is a 
safe and potentially beneficial intervention for people 
with MS. Considerations for clinical application in-
clude the ability to comfortably position individuals 
with mobility restrictions. Concerns related to MS 
often include the risk of causing an increase in symp-
toms, such as fatigue, pain or spasticity. However, this 
study showed that not only is MT safe for people with 
MS, but also that it may be an important adjunctive 
therapy, given that traditional approaches often do 
not ameliorate their symptoms. 
If MT can decrease fatigue and pain in some people 
with MS, this would provide at least some people 
with MS improved well-being and QOL. Given 
the state of health care reimbursement, providing 
evidence to support the use of interventions is criti-
cal in order to get paid for those interventions. This 
issue is even more important for people with MS, 
who have a chronic disease and resulting long-term 
health care needs. 
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